That’s an average of about 67,934 new infections every day. Or like a new infection every 1.2 seconds since January 21, 2020.
“It is, first of all, good news to see that curve bend down a little. We’re still at a very high level of infections,” said Dr. Ashish Jha, dean of the Brown University School of Public Health.
“But I am very worried about whether we’re going to be able to sustain this or not. If we move quickly on vaccinations … then we can keep that curve heading down. But if the variants take hold first, that curve will turn back up. And things will get much worse,” he said.
“So this is a race. Obviously I hope we win.”
Fauci: One of the new strains could be deadlier
A variant strain called B.1.1.7, first identified in the United Kingdom, is particularly concerning.
It’s been detected in at least 22 US states, according to data posted Friday by the Centers for Disease Control and Prevention.
A UK report released Friday said there’s “a realistic possibility” that B.1.1.7 has a higher death rate than other variants.
“The data is mounting — and some of it I can’t share — that clearly supports that B.1.1.7 is causing more severe illness and increased death,” said Michael Osterholm, director of the Center for Infectious Disease Research and Policy at the University of Minnesota.
“Already we know this variant has increased transmission, and so this is more very bad news.”
Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, said it’s certainly possibly this strain could be more harmful.
“We need to assume now that what has been circulating dominantly in the UK does have a certain degree of increase in what we call virulence, namely the power of the virus to cause more damage including death,” Fauci said told CBS’ “Face the Nation” on Sunday.
He noted that the research is still evolving.
“The data that came out was after they had been saying all along that it did not appear to be more deadly, so that’s where we got that information,” Fauci said.
The director of the National Institutes of Health, Dr. Francis Collins said Saturday it’s still too soon to tell if the B.1.1.7 variant is deadlier, saying the data is “very preliminary.”
“It looks as if, if you look at 1,000 people who got infected with Covid-19, generally about 1%, 10 of them, would die of it. Maybe with this virus, it would be 13 instead of 10,” Collins told MSNBC. “That’s a small difference.”
He added that increased mortality could be a “consequence of the fact that the UK health system is really overwhelmed.”
“That has an effect also on mortality,” Collins added.
In the US, Washington state health officials said they found the variant in testing samples in the state.
“We’re now in that second half of fighting this pandemic,” Washington Secretary of Health Umair A. Shah said Saturday.
“It’s very important for us to really double down on our efforts to prevent this strain as well as any strain from taking over, because we want to make sure that transmission does not happen in our state and the best way to do that is prevention, prevention, prevention.”
And that the same measures that can help prevent coronavirus infections in the past — wearing masks, social distancing and frequent hand washing — also fight against variant strains.
20.5 million vaccine doses administered in US
“I would anticipate that within a period of likely no more than two weeks, that the data will be looked at by the Data and Safety Monitoring Board,” Fauci told MSNBC.
If the data is strong enough, the next step would be presenting it to the Food and Drug Administration for an emergency use authorization.
“Let’s say they do … get an EUA in February, by the time they get a meaningful amount of doses, it likely will be a month or two following that,” he said. “Once they get going into May, June, July, August, then you’re going to see a sharp escalation of additional doses of this one-dose vaccine.”
The FDA says ‘modest delays’ are OK
Meanwhile, the FDA also told CNN Saturday that if absolutely necessary, “modest delays” between first and second doses of the current Covid-19 vaccines are not expected to decrease protection against the virus.
The agency said it “recognizes that getting as many people as possible across the country fully immunized will help to curtail the spread of the virus that causes COVID-19 and should be a priority.”
Previously, the FDA had warned changes to vaccine schedules without appropriate data could put public health at risk.
The CDC also updated its guidance to say second doses of vaccines may be scheduled up to six weeks after initial doses, if necessary, adding second doses should be administered as close as possible to the recommended interval — three weeks after the first dose for the Pfizer/BioNTech vaccine and four weeks for the Moderna vaccine.
Hospital leader: ‘We truly are in the darkest days’
That all comes as the US continues to fight a brutal battle against the virus.
And more than 6,800 people remain hospitalized with the virus — 24% of whom are in the ICU.
“While we are seeing some positive data in daily new cases and hospitalizations, we are far from out of the woods,” Public Health Director Barbara Ferrer said.
“It is critically important we slow COVID-19 spread to decompress the strain on our healthcare system and save lives.”
In Georgia, one health care official described a grim image of the grip of the virus.
“We truly are in the darkest days of this pandemic,” said Dr. Deepak Aggarwal at the Northeast Georgia Medical Center on Saturday night.
“We are seeing more than 200 patients per day now, than we normally see at this time of the year. “
“And also, we’re dealing with the increasing number of deaths,” Aggarwal said.
“Our system normally deals with less than 10 deaths per month.” But by January 21, “we have already had 169 deaths.”
CNN’s Naomi Thomas, Michael Nedelman, Lauren Mascarenhas, Elizabeth Cohen and Carma Hassan contributed to this report.